← Open Payments lookup

CARLYN PENTZIEN: Open Payments

NPI 1124534516 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$342 in 16 payments from 6 companies in 2025. Trend: 2023 $184 · 2024 $228 · 2025 $342

Food & beverage: $342
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.5$115
CooperSurgical, Inc.3$79
Octapharma USA, Inc.2$50
Astellas Pharma US Inc2$36
Biogen, Inc.2$33
Exeltis, USA Inc.2$30

Products named: MYFEMBREE, Paragard T 380A, FIBRYGA, Veozah, ZURZUVAE, SLYND.

Industry payments across NE — which companies pay providers there.